Adenosine in the spinal cord and periphery: Release and regulation of pain

Progress in Neurobiology

Volumn 69, Issue 5, 2003, Pages 313-340

  Sawynok, Jana ^a   Liu, Xue Jun ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

5' AMINO 5' DEOXYADENOSINE; ADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; BIOGENIC AMINE; CAPSAICIN; FORMALDEHYDE; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID; NEUROTRANSMITTER; OPIATE; SEROTONIN; SODIUM; SUBSTANCE P; VERATRIDINE;

ANTINOCICEPTION; CENTRAL NERVOUS SYSTEM; DEPOLARIZATION; DRUG EFFECT; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; NERVE INJURY; NERVE STIMULATION; NEUROGENIC INFLAMMATION; NEUROMODULATION; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; REVIEW; SENSITIZATION; SENSORY NERVE; SIGNAL TRANSDUCTION; SPINAL ANESTHESIA; SPINAL CORD; STAINING; STIMULUS RESPONSE; SYNAPTOSOME;

EID: 0038689146     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(03)00050-9     Document Type: Review

References (299)

1. Abbracchio M.P., Burnstock G. Purinergic signalling: pathophysiological roles. Jpn. J. Pharmacol. 78:1998;113-145.
2. Adanin S., Vityalovetsky I., Nardulli B.A., Sam A.D., Jonjev Z.S., Law W.R. Inhibiting adenosine deaminase modulates the systemic inflammatory response syndrome in endotoxemia and sepsis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282:2002;R1324-R1332.
3. 1 antinociception, tolerance and withdrawal. J. Neurosci. 17:1997;735-744.
4. Aley K.O., Green P.G., Levine J.D. Opioid and adenosine peripheral antinociception are subject to tolerance and withdrawal. J. Neurosci. 15:1995;8031-8038.
5. Allen B.J., Rogers S.D., Ghilardi J.R., Menning P.M., Kuskowski M.A., Basbaum A.I., Simone D.A., Mantyh P.W. Noxious cutaneous thermal stimuli induce a graded release of endogenous substance P in the spinal cord: imaging peptide action in vivo. J. Neurosci. 17:1997;5921-5927.
6. Anderson C.A., Baldwin S.A., Young J.D., Cass C.E., Parkinson F.E. Distribution of mRNA encoding a nitrobenzylthioinosine-insensitive nucleoside transporter (ENT2) in rat brain. Mol. Brain Res. 70:1999a;293-297.
7. Anderson C.M., Xiong W., Geiger J.D., Yound J.D., Cass C.E., Baldwin S.A., Parkinson F.E. Distribution of equilibrative, nitrobenzylthioinosine-sensitive nucleoside transporters (ENT1) in brain. J. Neurochem. 73:1999b;867-873.
8. Attal N., Bouhassira D. Mechanisms of pain in peripheral neuropathy. Acta Neurol. Scand. 173:1999;12-24.
9. Bantel C., Childers S.R., Eisenach J.C. Role of adenosine receptors in spinal G-protein activation after peripheral nerve injury. Anesthesiology. 96:2002a;1443-1449.
10. 1 receptor binding. Anesthesiology. 96:2002b;103-108.
11. Barber L.A., Vasko M.R. Activation of protein kinase C augments peptide release from rat sensory neurons. J. Neurochem. 67:1996;72-80.
12. 2X receptors mediate fast synaptic transmission in the dorsal horn of the rat spinal cord. J. Neurosci. 17:1997;5297-5304.
13. Belfrage M., Segerdahl M., Arnér S., Sollevi A. The safety and efficacy of intrathecal adenosine in patients with chronic neuropathic pain. Anesth. Analg. 89:1999;136-142.
14. Besse D., Lombard M.C., Zajac J.M., Roques B.P., Besson J.M. Pre- and postsynaptic distribution of μ, δ and κ opioid receptors in the superficial layers of the cervical dorsal horn of the rat spinal cord. Brain Res. 521:1990;15-22.
15. Bevan, S., 1999. Nociceptive peripheral neurons: cellular properties. In: Wall, P.D., Melzack, R. (Eds.), Textbook of Pain, fourth ed. Churchill Livingstone, Edinburgh, pp. 85-103.
16. Bland-Ward P.A., Humphrey P.P.A. Acute nociception mediated by hindpaw P2X receptor activation in the rat. Br. J. Pharmacol. 122:1997;365-371.
17. Bland-Ward P.A., Humphrey P.P.A. P2X receptors mediate ATP-induced primary nociceptive neurone activation. J. Auton. Nerv. Syst. 81:2000;146-151.
18. Bong G.W., Rosengren S., Firestein G.S. Spinal cord adenosine receptor stimulation in rats inhibits peripheral neutrophil accumulation. The role of N-methyl-D-aspartate receptors. J. Clin. Invest. 98:1996;2779-2785.
19. Boyle D.L., Kowaluk E.A., Jarvis M.F., Lee C.H., Bhagwat S.S., Williams M., Firestein G.S. Anti-inflammatory effects of ABT-702, a novel non-nucleoside adenosine kinase inhibitor, in rat adjuvant arthritis. J. Pharmacol. Exp. Ther. 296:2001a;495-500.
20. Boyle D.L., Moore J., Yang L., Sorkin L., Firestein G.S. Regulation of peripheral inflammation by the central nervous system (CNS): role of somatic afferent neurons. Arthritis Rheum. 44(Suppl.):2001b;S388.
21. Boyle D.L., Moore J., Yang L., Sorkin L.S., Firestein G.S. Spinal adenosine receptor activation inhibits inflammation and joint destruction in rat adjuvant-induced arthritis. Arthritis Rheum. 46:2002;3076-3082.
22. 3 purinoreceptors in sensory neurons: effects of axotomy and glial-derived neurotrophic factor. Mol. Cell. Neurosci. 12:1998;256-268.
23. Brain, S.D., 1996. Sensory neuropeptides in the skin. In: Gepetti, P., Holzer, P. (Eds.), Neurogenic Inflammation. CRC Press, Boca Raton, FL, pp. 229-244.
24. Bridges D., Thompson S.W.N., Rice A.S.C. Mechanisms of neuropathic pain. Br. J. Anaesth. 87:2001;12-26.
25. Brodin P., Burnstock G. Purinergic signalling: ATP release. Neurochem. Res. 26:2001;959-969.
26. Brundege J.M., Diao L., Proctor W.R., Dunwiddie T.V. The role of cyclic AMP as a precursor of extracellular adenosine in the rat hippocampus. Neuropharmacology. 36:1997;1201-1210.
27. Burgard E.C., Niforatos W., van Biesen T., Lynch K.J., Touma E., Metzger R.E., Kowaluk E.A., Jarvis M.F. P2X-mediated ionic currents in dorsal root ganglion neurons. J. Neurophysiol. 82:1999;1590-1598.
28. Burnstock G. Noradrenaline and ATP: cotransmitters and neuromodulators. J. Physiol. Pharmacol. 46:1995;365-384.
29. Burnstock G. P2X receptors in sensory neurones. Br. J. Anaesth. 84:2000;476-488.
30. Burnstock G., Williams M. P2 purinergic receptors: modulation of cell function and therapeutic potential. J. Pharmacol. Exp. Ther. 295:2000;862-869.
31. 2+ channels in depolarization-evoked release of adenosine from spinal cord synaptosomes. J. Neurochem. 60:1993a;886-893.
32. 2+ channels to release adenosine from spinal cord synaptosomes. J. Neurochem. 60:1993b;894-901.
33. Cahill C.M., White T.D., Sawynok J. Spinal opioid receptors and adenosine release: neurochemical and behavioural characterization of opioid subtypes. J. Pharmacol. Exp. Ther. 275:1995;84-93.
34. Cahill C.M., White T.D., Sawynok J. Synergy between mu/delta opioid receptors mediates adenosine release from spinal cord synaptosomes. Eur. J. Pharmacol. 298:1996;45-49.
35. Cahill C.M., White T.D., Sawynok J. Substance P releases adenosine and potentiates morphine-evoked release of adenosine from the rat spinal cord. Brain Res. 760:1997;294-297.
36. Carlton S.M. Peripheral excitatory amino acids. Curr. Opin. Pharmacol. 1:2001;52-56.
37. 1 receptor-mediated inhibition of protein kinase A-induced calcitonin gene-related peptide release from rat trigeminal neurons. Mol. Pharmacol. 59:2001;1533-1541.
38. Cass C.E., Young J.D., Baldwin S.A. Recent advances in the molecular biology of nucleoside transporters of mammalian cells. Biochem. Cell Biol. 76:1998;761-770.
39. 2A agonist ameliorates ischemic reperfusion injury in the rabbit spinal cord. Ann. Thorac. Surg. 72:2001a;1245-1250.
40. 2A agonist, ATL-146e, reduced paralysis and apoptosis during rabbit spinal cord reperfusion. J. Vasc. Surg. 34:2001b;482-488.
41. 2A receptor expression on motor neurons. Ann. Thorac. Surg. 74:2002;846-850.
42. Caterina M.J., Julius D. The vanilloid receptor: a molecular gateway to the pain pathway. Annu. Rev. Neurosci. 24:2001;487-517.
43. 2X purinoceptor expressed by a subset of sensory neurons. Nature. 377:1995;428-431.
44. 2A adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J. Neurosci. 19:1999;9192-9200.
45. Chen Y., Zhang Y.H., Zhao Z.Q. Novel purinergic sensitivity develops in injured sensory axons following sciatic nerve transection in rat. Brain Res. 911:2001;168-172.
46. 2 adenosine receptors in the rat spinal cord. J. Pharmacol. Exp. Ther. 242:1987;905-910.
47. 2 receptors of the substantia gelatinosa are located predominantly on intrinsic neurons: an autoradiography study. J. Pharmacol. Exp. Ther. 247:1988;757-764.
48. Circuela F., Saura C., Canela E.I., Mallol J., Lluis C., Franco R. Adenosine deaminase affects ligand-induced signalling by interacting with cell surface adenosine receptors. FEBS Lett. 380:1996;219-223.
49. Coderre T.J., Katz J., Vaccarino A.L., Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain. 52:1993;259-285.
50. 1 agonist blocks NMDA-evoked release of excitatory amino acids and adenosine as measured by intrathecal loop microdialysis. Soc. Neurosci. Abstr. 24:1998;1629.
51. Conway C.M., Marsala M., Somogyi G.T., Yaksh T.L. Intrathecal NMDA-induced release of spinal adenosine and amino acids. Soc. Neurosci. Abstr. 23:1997;1013.
52. 2A facilitatory adenosine receptor activation balance depends on motor nerve stimulation paradigm at the rat hemidiaphragm. J. Neurophysiol. 76:1996;3910-3919.
53. Cotrina M.L., Lin J.H., Lopez-Garcia J.C., Naus C.C., Nedergaard M. ATP-mediated glia signalling. J. Neurosci. 20:2000;2835-2844.
54. Crain S.M., Shen K.F. Modulatory effects of Gs-coupled excitatory opioid receptor functions on opioid analgesia, tolerance, and dependence. Neurochem. Res. 21:1996;1347-1351.
55. Cronstein B.N. Adenosine, an endogenous anti-inflammatory agent. J. Appl. Physiol. 76:1994;5-13.
56. Cronstein, B.N., 1998. Adenosine and its receptors during inflammation. In: Serhan, C.N., Ward, P.A. (Eds.), Molecular and Cellular Basis of Inflammation. Humana Press, Totowa, NJ, pp. 259-274.
57. Cronstein B.N., Naime D., Ostad E. The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J. Clin. Invest. 92:1993;2675-2682.
58. Cronstein B.N., Naime D., Firestein G. The antiinflammatory effects of an adenosine kinase inhibitor are mediated by adenosine. Arthritis Rheum. 38:1995;1040-1045.
59. Cronstein B.N., Montesinos M.C., Weissmann G. Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFκB. Proc. Natl. Acad. Sci. U.S.A. 96:1999;6377-6381.
60. Cunha R.A., Correia-de-Sá P., Sebastião A.M., Ribeiro J.A. Preferential activation of excitatory adenosine receptors at rat hippocampal and neuromuscular synapses by adenosine formed form released adenine nucleotides. Br. J. Pharmacol. 119:1996;253-260.
61. Daemen M.A.R.C., Kurvers H.A.J.M., Kitslaar J.E.H.M., Slaaf D.W., Bullens P.H.J., Van den Wildenberg F.A.J.M. Neurogenic inflammation in an animal model of neuropathic pain. Neurol. Res. 20:1998;41-45.
62. Damas J., Liégois J.F. The inflammatory reaction induced by formalin in the rat paw. Naunyn Schmiedebergs Arch. Pharmacol. 359:1999;220-227.
63. DeLander G.E., Hopkins C.J. Spinal adenosine modulates descending antinociceptive pathways stimulated by morphine. J. Pharmacol. Exp. Ther. 239:1986;88-93.
64. DeLander G.E., Hopkins C.J. Interdependence of spinal adenosinergic, serotonergic and noradrenergic systems mediating antinociception. Neuropharmacology. 26:1987;1791-1794.
65. DeLander G.E., Mosberg H.I., Porreca F. Involvement of adenosine in antinociception produced by spinal or supraspinal receptor-selective opioid agonists: dissociation from gastrointestinal effects in mice. J. Pharmacol. Exp. Ther. 263:1992;1097-1104.
66. DeLeo J.A., Yesierski R.P. The role of neuroinflammation and neuroimmune activation in persistent pain. Pain. 90:2001;1-6.
67. Dellemijn P. Are opioids effective in relieving neuropathic pain? Pain. 80:1999;453-462.
68. De Mendonça A., Sebastião A.M., Ribeiro A. Adenosine: does it have a neuroprotective role after all? Brain Res. Rev. 33:2000;258-274.
69. 1 receptors reduce release from excitatory but not inhibitory synaptic inputs onto lateral horn neurons. J. Neurosci. 21:2001;6308-6320.
70. 1 receptor stimulated increases in intracellular calcium in the smooth muscle cell line DDT1MF-2. Br. J. Pharmacol. 109:1993;719-724.
71. 1 receptor to phospholipase C in transfected CHO cells. Eur. J. Pharmacol. 355:1998;85-92.
72. Dickenson A.H., Suzuki R., Reeve A.J. Adenosine as a potential analgesic target in inflammatory and neuropathic pains. CNS Drugs. 13:2000;77-85.
73. Doak G.J., Sawynok J. Complex role of peripheral adenosine in the genesis of the response to subcutaneous formalin in the rat. Eur. J. Pharmacol. 281:1995;311-318.
74. Docherty R.J., Yeats J.C., Bevan S., Boddeke H.W. Inhibition of calcineurin inhibits the desensitization of capsaicin-evoked currents in cultured dorsal root ganglion neurones from adult rats. Pflugers Arch. 431:1996;828-837.
75. Doi T., Kuzuna S., Maki Y. Spinal antinociceptive effects of adenosine compounds in mice. Eur. J. Pharmacol. 137:1987;227-231.
76. Dolphin A.C., Forda S.R., Scott R.H. Calcium-dependent currents in cultured rat dorsal root ganglion neurons are inhibited by an adenosine analogue. J. Physiol. 373:1986;47-61.
77. Doubell, T.P., Mannion, R.J., Woolf, C.J., 1999. The dorsal horn: state-dependent sensory processing, plasticity and the generation of pain. In: Wall, P., Melzack, R. (Eds.), Textbook of Pain, fourth ed. Churchill Livingstone, Edinburgh, pp. 165-181.
78. 1 receptor-mediated excitation of nociceptive afferents innervating the normal and arthritic rat knee joint. Br. J. Pharmacol. 125:1998;1267-1271.
79. Driessen B., Reimann W., Selve N., Friedrichs E., Bültmann R. Antinociceptive effect of intrathecally administered P2-purinoceptor antagonists in rats. Brain Res. 666:1994;182-188.
80. Dubyak G., El-Moatissim C. Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am. J. Physiol. Cell Physiol. 265(34):1993;C577-C606.
81. Duggan A.W., Morton C.R., Zhao Z.Q., Hendry I.A. Noxious heating of the skin releases immunoreactive substance P in the substantia gelatinosa of the cat: a study with antibody microprobes. Brain Res. 403:1987;345-349.
82. Dunwiddie, T.V., Fredholm, B.B., 1997. Adenosine neuromodulation. In: Jacobson, K.A., Jarvis, M.F. (Eds.), Purinergic Approaches in Experimental Therapeutics. Wiley, New York, pp. 359-382.
83. Dunwiddie T.V., Masino S.A. The role and regulation of adenosine in the central nervous system. Annu. Rev. Neurosci. 24:2001;31-55.
84. Dunwiddie T.V., Diao L., Proctor W.E. Adenine nucleotides undergo rapid, quantitative conversion to adenosine in the extracellular space in rat hippocampus. J. Neurosci. 17:1997;7673-7682.
85. Durnett Richardson J., Vasko M.R. Cellular mechanisms of neurogenic inflammation. J. Pharmacol. Exp. Ther. 302:2002;839-845.
86. Eisenach J.C., Hood D.H., Curry R. Preliminary efficacy assessment of intrathecal injection of an American formulation of adenosine in humans. Anesthesiology. 96:2002;29-34.
87. Esquisatto L.C.M., Costa S.K.P., Camargo E.A., Ribela M.T.C.P., Brain S.D., de Nucci G., Antunes E. The plasma protein extravasation induced by adenosine and its analogues in the rat dorsal skin: evidence for the involvement of capsaicin sensitive primary afferent neurones and mast cells. Br. J. Pharmacol. 134:2001;108-115.
88. 2+ wave propagation on dorsal spinal cord astrocytes. J. Neurosci. 20:2000;2800-2808.
89. 2+ signalling by PKC in astrocytes. Soc. Neurosci. Abstr. 27, Program No. 572.14.
90. 2B receptors. Pharmacol. Rev. 49:1997;381-402.
91. 2B receptors mediate an increase in interleukin (IL)-6 mRNA and IL-6 protein synthesis in human astroglioma cells. J. Neurochem. 66:1996a;1426-1431.
92. 2A-receptors. Glia. 18:1996b;152-160.
93. Field M.J., Bramwell S., Hughes J., Singh L. Detection of static and dynamic components of mechanical allodynia in rat models of neuropathic pain: are they signalled by distinct primary sensory neurones? Pain. 83:1999;303-311.
94. Fields, H.L., 1987. Pain. McGraw-Hill, New York.
95. Fields R.D., Stevens B. ATP: an extracellular signalling molecule between neurons and glia. Trends Neurosci. 23:2000;625-633.
96. Firestein G.S. Anti-inflammatory effects of adenosine kinase inhibitors in acute and chronic inflammation. Drug Dev. Res. 39:1996;371-376.
97. Franco R., Casadó V., Circuela F., Saira C., Mallol J., Canela E.I., Lluis C. Cell surface adenosine deaminase: much more than an ectoenzyme. Prog. Neurobiol. 52:1997;283-294.
98. Fredholm B.B. Adenosine and neuroprotection. Int. Rev. Neurobiol. 40:1997;259-280.
99. Fredholm B.B., Ijzerman A.P., Jacobson K.A., Klotz K.N., Linden J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53:2001;527-552.
100. Fukuhara N., Imai Y., Sakakibara A., Morita K., Kitayama S., Tanne K., Dohi T. Regulation of the development of allodynia by intrathecally administered P2 purinoceptor agonists and antagonists in mice. Neurosci. Lett. 292:2000;25-28.
101. Fyffe R.E.W., Perl E.R. Is ATP a central synaptic mediator for certain primary afferent fibers from mammalian skin? Proc. Natl. Acad. Sci. U.S.A. 81:1984;6890-6893.
102. Gadangi P., Longaker M., Naime D., Levin R.I., Recht P.A., Montesinos M.C., Buckley M.T., Carlin G., Cronstein B.N. The anti-inflammatory mechanism of sulfasalazine is related to adenosine release at inflamed sites. J. Immunol. 156:1996;1937-1941.
103. Gallagher, C.J., Salter, M.W., 1999. Nucleotide receptor signalling in spinal cord astrocytes: findings and functional implications. In: Illes, P., Zimmermann, H. (Eds.), Progress in Brain Research, vol. 120. Elsevier, Amsterdam, pp. 311-322.
104. 2 receptors are required to stimulate microglial proliferation. Neurochem. Int. 29:1997;37-42.
105. Geiger J.D., LaBella F.S., Nagy J.I. Characterization and localization of adenosine receptors in rat spinal cord. J. Neurosci. 4:1984;2303-2310.
106. Geiger, J.D., Parkinson, F.E., Kowaluk, E.A., 1997. Regulators of endogenous adenosine levels as therapeutic agents. In: Jacobson, K.A., Jarvis, M.F. (Eds.), Purinergic Approaches in Experimental Therapeutics. Wiley, New York, pp. 55-84.
107. 1 and bradykinin receptors increases protein kinase C and phospholipase D activity in smooth muscle cell line. Mol. Pharmacol. 41:1995;587-597.
108. Gold M.S. Spinal nerve ligation: what to blame for the pain and why. Pain. 84:2000;117-120.
109. Golembiowska K., White T.D., Sawynok J. Modulation of adenosine release from rat spinal cord by adenosine deaminase and adenosine kinase inhibitors. Brain Res. 699:1995;315-320.
110. Golembiowska K., White T.D., Sawynok J. Adenosine kinase inhibitors augment release of adenosine from spinal cord slices. Eur. J. Pharmacol. 307:1996;157-162.
111. Gomes J.A., Li X., Pain H.L., Eisenach J.C. Intrathecal adenosine interacts with a spinal noradrenergic system to produce antinociception in nerve-injured rats. Anesthesiology. 91:1999;1072-1079.
112. Grubb B.D., Evans R.J. Characterization of cultured dorsal root ganglion neuron P2X receptors. Eur. J. Neurosci. 11:1999;149-154.
113. Gu J.G., McDermott A.B. Activation of ATP P2X receptors elicits glutamate release from sensory neuron synapses. Nature. 389:1997;749-753.
114. Guieu R., Peragut J.C., Hassani H., Sampieri F., Bechis G., Gola R., Rochat H. Adenosine and neuropathic pain. Pain. 68:1996;271-274.
115. Guo Y., Mochizuki T., Morii E., Kitamura Y., Maeyama K. Role of mast cell histamine in the formation of rat paw edema: a microdialysis study. Eur. J. Pharmacol. 331:1997;237-243.
116. 4 binding site. Eur. J. Neurosci. 11:1999;946-958.
117. Guthrie P.B., Knappenberger J., Segal M., Bennett M.V.L., Charles A.C., Kater S.B. ATP released from astrocytes mediates glial calcium waves. J. Neurosci. 19:1999;520-528.
118. Hamilton S.G., McMahon S.B. ATP as a peripheral mediator of pain. J. Auton. Nerv. Syst. 81:2000;187-194.
119. Hamilton S.G., Wade A., McMahon S.B. The effects of inflammation and inflammatory mediators on nociceptive behaviour induced by ATP analogues in the rat. Br. J. Pharmacol. 126:1999;326-332.
120. 3 receptors decreases interleukin-12 and interferon-γ production and prevents lethality in endotoxemic mice. Eur. J. Pharmacol. 358:1998;261-268.
121. Haydon P.G. Glia: listening and talking to the synapse. Nat. Neurosci. Rev. 2:2001;185-193.
122. Holton P. The liberation of adenosine triphosphate on antidromic stimulation of sensory nerves. J. Physiol. 145:1959;494-504.
123. Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience. 24:1988;739-768.
124. Holzer P. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol. Rev. 43:1991;143-201.
125. Holzer P. Neurogenic vasodilation and plasma leakage in the skin. Gen. Pharmacol. 30:1998;5-11.
126. 1 receptors. J. Physiol. 508:1998;109-118.
127. Hoyle C.H.V. Purinergic cotransmission: parasympathetic and enteric nerves. Semin. Neurosci. 8:1996;207-215.
128. Hudson L.J., Bevan S., Wotherspoon G., Gentry C., Fox A., Winter J. VR1 protein expression increases in undamaged DRG neurons after partial nerve injury. Eur. J. Neurosci. 13:2001;2105-2114.
129. Hugel S., Schlichter R. Presynaptic P2X receptors facilitate inhibitory GABAergic transmission between cultured rat spinal cord dorsal horn neurons. J. Neurosci. 20:2000;2121-2130.
130. Inoue M., Ueda H. Protein kinase C-mediated acute tolerance to peripheral μ-opioid analgesia in the bradykinin-nociception test in mice. J. Pharmacol. Exp. Ther. 293:2000;662-669.
131. Irnich D., Burgstahler R., Bostock H., Grafe P. ATP affects both axons and Schwann cells of unmyelinated C fibres. Pain. 92:2001;343-350.
132. Jansco G., Kiraly E., Jansco-Gabor A. Pharmacologically induced selective degeneration of chemosensitive primary sensory neurons. Nature. 270:1977;741-743.
133. 3 homomeric and heteromeric channels in nociceptive signalling and behavior. Drug Dev. Res. 52:2001;220-231.
134. Jarvis M.F., Mikusa J., Chu K.L., Wismer C.T., Honore P., Kowaluk E.A., McGaraughty S. Comparison of the ability of adenosine kinase inhibitors and adenosine receptor agonists to attenuate thermal hyperalgesia and reduce motor performance in rats. Pharmacol. Biochem. Behav. 73:2002a;573-581.
135. Jarvis M.F., Yu H.Y., McGaraughty S., Wismer C.T., Mikusa J., Zhu C., Chu K., Kohlhaas K., Cowart M., Lee C.H., Stewart A.O., Cox B.F., Polakowski J., Kowaluk E.A. Analgesic and anti-inflammatory effects of A-286501, a novel orally active adenosine kinase inhibitor. Pain. 96:2002b;107-118.
136. Jo Y.H., Schlichter R. Synaptic corelease of ATP and GABA in cultured spinal neurons. Nat. Neurosci. 2:1999;241-245.
137. Julius D., Basbaum A.I. Molecular mechanisms of nociception. Nature. 413:2001;203-210.
138. 2A receptor gene in rat dorsal root and autonomic ganglia. Neurosci. Lett. 246:1998;21-24.
139. 2A receptors gene in the olfactory bulb and spinal cord of rat and mouse. Neurosci. Lett. 261:1999;189-191.
140. Kangra M., Randic M. Tachykinins and calcitonin gene-related peptide enhance release of endogenous glutamate and aspartate from the rat spinal dorsal horn slice. J. Neurosci. 10:1990;2026-2038.
141. Keil G.J., DeLander G.E. Spinally-mediated antinociception is induced in mice by an adenosine kinase-, but not by an adenosine deaminase-, inhibitor. Life Sci. 51:1992;171-176.
142. Keil G.J., DeLander G.E. Adenosine kinase and adenosine deaminase inhibition modulate spinal adenosine- and opioid agonist-induced antinociception in mice. Eur. J. Pharmacol. 271:1994;37-46.
143. Keil G.J., DeLander G.E. Time-dependent antinociceptive interactions between opioids and nucleoside transport inhibitors. J. Pharmacol. Exp. Ther. 274:1995;1387-1392.
144. Keil G.J., DeLander G.E. Altered sensory behaviors in mice following manipulation of endogenous spinal adenosine neurotransmission. Eur. J. Pharmacol. 312:1996;7-14.
145. 2 receptors in the rat. Brain Res. 808:1998;106-109.
146. Khasar S.G., Wang J.F., Taiwo Y.O., Heller P.H., Green P.G., Levine J.D. Mu-opioid agonist enhancement of prostaglandin-induced hyperalgesia in the rat: a G-protein βγ subunit-mediated effect? Neuroscience. 67:1995;189-195.
147. Kirkup A.J., Eastwood C., Frundy D., Chessell I.P., Huphrey P.P.A. Characterization of adenosine receptors evoking excitation of mesenteric afferents in the rat. Br. J. Pharmacol. 125:1998;1352-1360.
148. Kitakaze M., Morioka T., Minamino T., Takashima S., Okazaki Y., Node K., Komamura K., Iwakura K., Itoh T., Inoue M., Kamada T. α-Adrenoceptor activation increases ecto-5′-nucleotidase activity and adenosine release in rat cardiomyocytes by activating protein kinase C. Circulation. 91:1995;2226-2234.
149. 1 receptor agonist by cyclic AMP in the spinal cord of rats. Neurosci. Lett. 219:1996;195-198.
150. Koplas R.A., Rosenberg R.L., Oxford G.S. The role of calcium in the desensitization of capsaicin responses in rat dorsal root ganglion neurons. J. Neurosci. 17:1997;3525-3537.
151. Kowaluk E.A. Adenosine modulation: a novel approach to analgesia and inflammation. Exp. Opin. Invest. Drugs. 7:1998;535-543.
152. Kowaluk E.A., Jarvis M.F. Therapeutic potential of adenosine kinase inhibitors. Exp. Opin. Invest. Drugs. 9:2000;551-564.
153. Kowaluk E.A., Mikusa J., Wismer C.T., Zhu C.Z., Schweitzer E., Lynch J.J., Lee C.H., Jiang M.Q., Bhagwat S.S., Gomtsyan A., McKie J., Cox B.F., Polakowski J., Reinhart G., Williams M., Jarvis M.F. ABT-702, a novel orally effective adenosine kinase inhibitor with analgesia and anti-inflammatory properties. II. In vivo characterization in the rat. J. Pharmacol. Exp. Ther. 295:2000;1165-1174.
154. Labrakakis C., Gerstner E., McDermott A.B. Adenosine triphosphate-evoked currents in cultured dorsal root ganglion neurons obtained from rat embryos: desensitization kinetics and modulation of glutamate release. Neuroscience. 101:2000;1117-1126.
155. 1 adenosine receptor. Pain. 94:2001;315-324.
156. Latini S., Pedata F. Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J. Neurochem. 79:2001;463-484.
157. Lavand'homme P.M., Eisenach J.C. Exogenous and endogenous adenosine enhance the spinal antiallodynic effects of morphine in a rat model of neuropathic pain. Pain. 80:1999;31-36.
158. Lee Y.W., Yaksh T.L. Pharmacology of the spinal adenosine receptor which mediates the antiallodynic action of intrathecal adenosine agonists. J. Pharmacol. Exp. Ther. 277:1996;1642-1648.
159. Lee Y.W., Chaplan S.R., Yaksh T.L. Systemic and supraspinal, but not spinal, opiates suppress allodynia in a rat neuropathic pain model. Neurosci. Lett. 186:1995;111-114.
160. Levine, J.D., Reichling, D.B., 1999. Peripheral mechanisms of inflammatory pain. In: Wall, P.D., Melzack, R. (Eds.), Textbook of Pain, fourth ed. Churchill Livingstone, Edinburgh, pp. 59-84.
161. 3 receptor subunits can account for ATP-gated currents in sensory neurones. Nature. 377:1995;432-435.
162. Li J., Perl E.R. Adenosine inhibition of synaptic transmission in the substantia gelatinosa. J. Neurophysiol. 72:1994;1611-1621.
163. Li X., Conklin D., Ma W., Zhu X., Eisenach J.C. Spinal noradrenergic activation mediates allodynia reduction from an allosteric adenosine modulator in a rat model of neuropathic pain. Pain. 97:2002;117-125.
164. Linden J. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu. Rev. Pharmacol. Toxicol. 41:2001;775-787.
165. 1 receptor agonists and inhibitors of adenosine metabolism in a rat neuropathic pain model. Analgesia. 5:2000;19-29.
166. Liu H., Mantyh P.W., Basbaum A.I. NMDA-receptor regulation of substance P release from primary afferent nociceptors. Nature. 386:1997;721-724.
167. Liu X.J., White T.D., Sawynok J. Potentiation of formalin-evoked adenosine release by an adenosine kinase and an adenosine deaminase inhibitor in the rat hindpaw: a microdialysis study. Eur. J. Pharmacol. 408:2000;143-152.
168. Liu X.J., White T.D., Sawynok J. Involvement of primary sensory afferents, postganglionic sympathetic nerves and mast cells in the formalin-evoked peripheral release of adenosine. Eur. J. Pharmacol. 42:2001;147-155.
169. Liu X.J., White T.D., Sawynok J. Intraplantar injection of glutamate evokes peripheral adenosine release in the rat hindpaw: involvement of peripheral ionotropic glutamate receptors and capsaicin-sensitive sensory afferents. J. Neurochem. 80:2002a;562-570.
170. Liu X.J., White T.D., Sawynok J. Enhanced release of adenosine in rat hindpaw following spinal nerve ligation: involvement of capsaicin-sensitive sensory afferents. Neuroscience. 114:2002b;379-387.
171. Lynn B. Capsaicin: actions on nociceptive C-fibres and therapeutic potential. Pain. 41:1990;61-69.
172. MacDonald R.L., Skerritt J.H., Werz M.A. Adenosine agonists reduce voltage-dependent calcium conductance of mouse sensory neurons in cell culture. J. Physiol. 370:1986;85-90.
173. 2 using microdialysis in conscious rats. Br. J. Pharmacol. 114:1995;1069-1075.
174. 14C -2-deoxyglucose activity in rats with painful peripheral neuropathy Neurophysiology. 70:1993;470-481.
175. Mauborgne A., Poliénor H., Hamon M., Cesselin F., Bourgoin S. Adenosine receptor-mediated control of in vitro release of pain-related neuropeptides from the rat spinal cord. Eur. J. Pharmacol. 441:2002;47-55.
176. Mayer D.J., Mao J., Price D.D. The development of morphine tolerance and dependence is associated with translocation of protein kianse C. Pain. 61:1995;365-374.
177. 2A receptor activation reduces proinflammatory events and decreases cell death following intracerebral hemorrhage. Ann. Neurol. 49:2001;727-735.
178. McAdoo D.J., Robak G., Xu G.Y., Hughes M.G. Adenosine release upon spinal cord injury. Brain Res. 854:2000;152-157.
179. McCall W.D., Tanner K.D., Levine J.D. Formalin induces biphasic activity in C-fibers in the rat. Neurosci. Lett. 208:1996;45-48.
180. McGaraughty S., Chu K.L., Wismer C.T., Mikusa J., Zhu C.Z., Cowart M., Kowaluk E.A., Jarvis M.F. Effects of A-134974, a novel adenosine kinase inhibitor, on carrageenan-induced inflammatory hyperalgesia and locomotor activity in rats: evaluation of the sites of action. J. Pharmacol. Exp. Ther. 296:2001;501-509.
181. Michaelis, M., 2000. Coupling of sympathetic and somatosensory neurons following nerve injury: mechanisms and potential significance for the generation of pain. In: Devor, M., Rowbotham, M.C., Weisenfeld-Hallin, Z. (Eds.), Proceedings of the Ninth World Congress on Pain. Progress in Pain Research and Management, vol. 16. IASP Press, Seattle, pp. 645-656.
182. Millan M.J. The induction of pain: an integrative review. Prog. Neurobiol. 57:1999;1-164.
183. Montesinos, M.C., Cronstein, B.N., 2001. Role of P1 receptors in inflammation. In: Handbook of Experimental Pharmacology. Purinergic and Pyrimidinergic Signalling. II. Cardiovascular, Respiratory, Immune, Metabolic and Gastrointestinal Tract Function, vol. 151. Springer, New York, pp. 303-321.
184. 2 (GαS-linked) receptors. J. Exp. Med. 186:1997;1615-1620.
185. Montesinos M.C., Yap J.S., Desai A., Posadas I., McCrary C.T., Cronstein B.N. Reversal of the antiinflammatory effects of methotrexate by the nonselective adenosine receptor antagonists theophylline and caffeine. Arthritis Rheum. 43:2000;656-663.
186. 2A receptors. Am. J. Pathol. 160:2002;2009-2018.
187. Moore K.A., Kohno T., Scholz J., Karchewski L., Woolf C.J. Spinal disinhibition: a role in neuropathic pain? Neurosci. News. 4:2001;5-10.
188. Morabito L., Montesinos M.C., Schreibman D.M., Balter L., Thompson L.F., Resta R., Carlin G., Huie M.A., Cronstein B.N. Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5′-nucleotidase-mediated conversion of adenine nucleotides. J. Clin. Invest. 101:1998;295-300.
189. Nagaoka H., Sakurada S., Sakurada T., Takeda S., Nakagawa Y., Kisara K., Arai Y. Theophylline-induced nociceptive behavioral response in mice: possible indirect interaction with spinal N-methyl-D-aspartate receptors. Neurochem. Int. 22:1993;69-74.
190. Nagy J.I., Emson P.C., Iversen L.L. A re-evaluation of the neurochemical and antinociceptive effects of intrathecal capsaicin in the rat. Brain Res. 211:1981;497-502.
191. Nagy J.I., Iversen L.L., Goedert M., Chapman D., Hunt S.P. Dose-dependent effects of capsaicin on primary sensory neurons in the neonatal rat. J. Neurosci. 3:1983;399-406.
192. Nakamura I., Ohta Y., Kemmotsu O. Characterization of adenosine receptors mediating spinal sensory transmission related to nociceptive information in the rat. Anesthesiology. 87:1997;577-584.
193. Nakatsuka T., Gu J.G. ATP P2X receptor-mediated enhancement of glutamate release and evoked EPSPs in dorsal horn neurons of the rat spinal cord. J. Neurosci. 21:2001;6522-6531.
194. Neary J.T., Rathbone M.P., Cattabeni F., Abbracchio M.P., Burnstock G. Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells. Trends Neurosci. 19:1996;13-18.
195. Neumann S., Doubell T.P., Leslie T., Woolf C.J. Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons. Nature. 384:1996;360-364.
196. Nikbakht M.R., Stone T.W. Complex hippocampal responses to ATP: fade due to nucleotidase inhibition and P2-receptor-mediated adenosine release. Brain Res. 860:2000;161-165.
197. Noguchi N., Kawai Y., Fukuoka T., Senba E., Miki K. Substance P induced by peripheral nerve injury in primary afferent sensory neurons and its effect on dorsal column nucleus neurons. J. Neurosci. 15:1995;7633-7643.
198. 3 purinoceptors in sensory neurons in naïve rats and following neuropathic injury. Pain. 80:1999;273-282.
199. Obata T. Adenosine production and its interaction with protection of ischemic and reperfusion injury of the myocardium. Life Sci. 71:2002;2083-2103.
200. Obata T., Kubota S., Yamanaka Y. Histamine increases interstitial adenosine concentration via activation of ecto-5′-nucleotidase in rat hearts in vivo. J. Pharmacol. Exp. Ther. 298:2001;71-76.
201. 2 adenosine receptor cooperation. Eur. J. Neurosci. 8:1996;1124-1131.
202. Ohta A., Sitkovsky M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature. 414:2001;916-920.
203. Ossipov M.H., Bian D., Malan T.P., Lai J., Porreca F. Lack of involvement of capsaicin-sensitive primary afferents in nerve-ligation injury induced tactile allodynia in rats. Pain. 79:1999;127-133.
204. Ossipov M.H., Lai J., Malan T.P., Porreca F. Spinal and supraspinal mechanisms of neuropathic pain. Ann. N. Y. Acad. Sci. 909:2000;12-24.
205. Palermo N.N., Brown H.K., Smith D.L. Selective neurotoxic action of capsaicin on glomerular C-type terminals in rat substantia gelatinosa. Brain Res. 208:1981;506-510.
206. Park S.K., Chung K., Chung J.M. Effects of purinergic and adrenergic antagonists in a rat model of painful peripheral neuropathy. Pain. 87:2000;171-179.
207. 3H ]adenosine influx Biochem. Pharmacol. 46:1993;891-896.
208. Patel M.K., Pinnock R.D., Lee K. Adenosine exerts multiple effects on dorsal horn neurones of the adult rat spinal cord. Brain Res. 920:2001;19-26.
209. 2B-receptor mediated cyclic AMP accumulation in primary rat astrocytes. Br. J. Pharmacol. 111:1994;191-198.
210. Poon A., Sawynok J. Antinociception by adenosine analogs and inhibitors of adenosine metabolism in an inflammatory thermal hyperalgesia model in the rat. Pain. 74:1998;235-245.
211. Porreca F., Lai J., Bian N., Wegert S., Ossipov M.H., Eglen R.M., Kassotakis L., Novakovic S., Rabert D.K., Sangameswaran L., Hunter J.C. A comparison of the potential role of the tetrodotoxin insensitive sodium channels, PN3/SNS and NaN/SNS2, in rat models of chronic pain. Proc. Natl. Acad. Sci. U.S.A. 96:1999;7640-7644.
212. Post C. Antinociceptive effects in mice after intrathecal injection of 5′-ethylcarboxamide adenosine. Neurosci. Lett. 51:1984;325-330.
213. Price, D.D., Mao, J., Mayer, D.J., 1994. Central neural mechanisms of normal and abnormal pain states. In: Fields, H.L., Liebskind, J.C. (Eds.), Progress in Pain Research and Management, vol. 1. IASP Press, Seattle, pp. 61-84.
214. Puig S., Sorkin L.S. Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase-2 activity. Pain. 64:1995;345-355.
215. Queiróz G., Gebicke-Haerter P.J., Schobert A., Strake K., von Kügelen I. Release of ATP from cultured astrocytes elicited by glutamate receptor activation. Neuroscience. 78:1997;1203-1208.
216. Raja, S.N., Meyer, R.A., Ringkamp, M., Campbell, J.N., 1999. Peripheral neural mechanisms of nociception. In: Textbook of Pain, fourth ed. Churchill Livingstone, Edinburgh, pp. 11-57.
217. Rathbone M.P., Middlemiss P., Andrew C., Caciagli F., Ciccarelli R., Diloiro P., Huang R. The trophic effects of purines and purinergic signalling in pathogenic reactions of astrocytes. Alzheimer Dis. Assoc. Disord. 12:1998;S36-S45.
218. 3 receptors promote degranulation of rat mast cells both in vitro and in vivo. Inflamm. Res. 46:1997;180-184.
219. Rhee J.S., Wang Z.M., Nabekura J., Inoue K., Akaike N. ATP facilitates spontaneous glycinergic IPSC frequency at dissociated rat dorsal horn interneuron synapses. J. Physiol. 524:2000;471-483.
220. Ribeiro J.A., Sebastião A.M., de Mendonça A. Adenosine receptors in the nervous system: pathophysiological implications. Prog. Neurobiol. 68:2003;377-392.
221. 1 immunoreactivity in the rat dorsal horn, and its relationship to transmitter-related substances and receptors. Soc. Neurosci. Abstr. 27, Program No. 158.15.
222. Rosenberg P.A., Li Y. Adenylyl cyclase activation underlies intracellular cyclic AMP accumulation, cyclic AMP transport, and extracellular adenosine accumulation evoked by β-adrenergic receptor stimulation in mixed cultures of neurons and astrocytes derived from rat cerebral cortex. Brain Res. 692:1995;227-232.
223. Rosengren S., Bond G.W., Firestein G.S. Anti-inflammatory effects of an adenosine kinase inhibitor. J. Immunol. 154:1995;5444-5451.
224. Sala-Newby G.B., Skladanowski A.C., Newby A.C. The mechanism of adenosine formation in cells - cloning of cytosolic 5′-nucleotidase. J. Biol. Chem. 274:1999;17789-17793.
225. Salter M.W., Hicks J.L. ATP-evoked increases in intracellular calcium in cultured neurons and glia form the dorsal spinal cord. J. Neurosci. 14:1994;1563-1575.
226. 3 pathway in astrocytes from the dorsal spinal cord. J. Neurosci. 15:1995;2961-2971.
227. Salter M.W., de Koninck Y., Henry J.L. Physiological roles for adenosine and ATP in synaptic transmission in the spinal dorsal horn. Prog. Neurobiol. 41:1993;125-156.
228. 3 adenosine receptor gene in mice and its effect on stimulated inflammatory cells. J. Biol. Chem. 275:2000;4429-4434.
229. Sandner-Kiesling A., Li X., Eisenach J.C. Morphine-induced spinal release of adenosine is reduced in neuropathic rats. Anesthesiology. 95:2001;1455-1459.
230. Santicioli P., Del Bianco E., Tramontana M., Maggi C.A. Adenosine inhibits action potential-dependent release of calcitonin gene-related peptide- and substance P-like immunoreactivities from primary afferents in rat spinal cord. Neurosci. Lett. 144:1992;211-214.
231. 1 receptors mediate the presynaptic inhibition of calcitonin gene-related peptide release by adenosine in the rat spinal cord. Eur. J. Pharmacol. 231:1993;139-142.
232. Sarne Y., Fields A., Keren O., Gafni M. Stimulatory effects of opioids on transmitter release and possible cellular mechanisms: overview and original results. Neurochem. Res. 21:1996;1353-1361.
233. 1 adenosine receptor internalize together following agonist-induced receptor desensitization. J. Biol. Chem. 273:1998;17610-17617.
234. Sawynok J. Adenosine receptor activation and nociception. Eur. J. Pharmacol. 317:1998;1-11.
235. Sawynok J. Purines in pain management. Curr. Opin. Cent. Periph. Nerv. Syst. Invest. Drugs. 1:1999;27-38.
236. Sawynok J., Reid A. Interactions of descending serotonergic systems with other neurotransmitters in the modulation of nociception. Behav. Brain Res. 73:1996;63-68.
237. Sawynok J., Reid A. Peripheral adenosine 5′-triphosphate enhances nociception in the formalin test via activation of a purinergic P2X receptor. Eur. J. Pharmacol. 330:1997;115-121.
238. Sawynok J., Sweeney M.I., White T.D. Classification of adenosine receptors mediating antinociception in the rat spinal cord. Br. J. Pharmacol. 88:1986;923-930.
239. Sawynok J., Sweeney M., Nicholson D., White T.D. Pertussis toxin inhibits morphine-induced release of adenosine from the spinal cord. Prog. Clin. Biol. Res. 328:1990;397-400.
240. Sawynok J., Espey M.J., Reid A.R. 8-Phenyltheophylline reverses the antinociceptive action of morphine microinjected into the periaqueductal gray region of the rat. Neuropharmacology. 30:1991a;871-877.
241. Sawynok J., Reid A., Nance D. Spinal antinociception by adenosine analogs and morphine following intrathecal administration of the neurotoxins capsaicin, 6-hydroxydopamine and 5,7-dihydroxytryptamine. J. Pharmacol. Exp. Ther. 258:1991b;370-380.
242. Sawynok J., Downie J.W., Reid A.R., Cahill C.M., White T.D. ATP release from dorsal spinal cord synaptosomes: characterization and neuronal origin. Brain Res. 610:1993;32-38.
243. 3 receptor activation produces nociceptive behavior and edema by release of histamine and 5-hydroxytryptamine. Eur. J. Pharmacol. 333:1997;1-7.
244. Sawynok J., Reid A., Poon A. Peripheral antinociceptive effect of an adenosine kinase inhibitor, with augmentation by an adenosine deaminase inhibitor, in the rat formalin test. Pain. 74:1998;75-81.
245. 3 receptor agonists. Eur. J. Pharmacol. 386:1999;253-261.
246. 2B/3 receptor agonists. Eur. J. Pharmacol. 395:2000;47-50.
247. 2-receptor mediated excitatory actions on the nervous system. Prog. Neurobiol. 48:1996;167-189.
248. Segerdahl M., Sollvei A. Adenosine and pain relief: a clinical overview. Drug Dev. Res. 45:1998;151-158.
249. Siegmund B., Reider F., Albrich S., Wolf K., Bidlingmaier C., Firestein G.S., Boyle D., Lehr H.A., Loher F., Hartmann G., Endres S., Eigler A. Adenosine kinase inhibitor GP515 improves experimental colitis in mice. J. Pharmacol. Exp. Ther. 296:2001;99-105.
250. 1 adenosine receptor activation. Biochem. Pharmacol. 59:2000;477-483.
251. Skilling S.R., Smullin D.H., Beitz A.J., Larson A.A. Extracellular amino acid concentrations in the dorsal spinal cord of freely moving rats following veratridine and nociceptive stimulation. J. Neurochem. 51:1988;127-132.
252. Smart D., Lambert D.G. The stimulatory effects of opioids and their possible role in the development of tolerance. Trends Pharmacol. Sci. 17:1996;264-269.
253. Snider W.D., McMahon S.B. Tackling pain at the source: new ideas about nociceptors. Neuron. 20:1998;629-632.
254. Stevens C.W., Seybold V.S. Changes of opioid binding density in the rat spinal cord following unilateral dorsal rhizotomy. Brain Res. 687:1995;53-62.
255. Suarez-Roca H., Maixner W. Morphine produces a multiphasic effect on the release of substance P from rat trigeminal nucleus slices by activating different opioid receptor subtypes. Brain Res. 579:1992;195-203.
256. Suh H.W., Song D.K., Kim Y.H. Differential effects of adenosine receptor antagonists injected intrathecally on antinociception induced by morphine and β-endorphin administered intracerebroventricularly in the mouse. Neuropeptides. 31:1997;339-344.
257. Suzuki R., Stanfa L.C., Kowaluk E.A., Williams M., Jarvis M.F., Dickenson A.H. The effect of ABT-702, a novel adenosine kinase inhibitor, on the responses of spinal neurones following carrageenan inflammation and peripheral nerve injury. Br. J. Pharmacol. 132:2001;1615-1623.
258. Sweeney M.I. Adenosine release and uptake in cerebellar granule neurons both occur via an equilibrative nucleoside carrier that is modulated by G proteins. J. Neurochem. 67:1996;81-88.
259. Sweeney M.I., White T.D., Jhamandas K.H., Sawynok J. Morphine releases endogenous adenosine from the spinal cord in vivo. Eur. J. Pharmacol. 141:1987a;169-170.
260. Sweeney M.I., White T.D., Sawynok J. Involvement of adenosine in the spinal antinociceptive effects of morphine and noradrenaline. J. Pharmacol. Exp. Ther. 243:1987b;657-665.
261. Sweeney M.I., White T.D., Sawynok J. 5-Hydroxytryptamine releases adenosine from primary afferent terminals in the spinal cord. Brain Res. 462:1988;346-349.
262. + release purines from capsaicin-sensitive primary afferent nerve terminals in the spinal cord. J. Pharmacol. Exp. Ther. 248:1989;447-454.
263. Sweeney M.I., White T.D., Sawynok J. 5-Hydroxytryptamine releases adenosine and cyclic AMP from primary afferent nerve terminals in the spinal cord in vivo. Brain Res. 528:1990;187-195.
264. Sweeney M.I., White T.D., Sawynok J. Intracerebroventricular morphine releases cyclic AMP and adenosine from the spinal cord via a serotonergic mechanism. J. Pharmacol. Exp. Ther. 259:1991;1013-1018.
265. Sweeney M.I., White T.D., Sawynok J. Morphine-evoked release of adenosine from the spinal cord occurs via a nucleoside carrier with differential sensitivity to dipyridamole and nitrobenzylthioinosine. Brain Res. 614:1993;301-307.
266. Sweitzer S.M., Schubert P., DeLeo J.A. Propentofylline, a glial modulating agent, exhibits antiallodynic properties in a rat model of neuropathic pain. J. Pharmacol. Exp. Ther. 297:2001;1210-1217.
267. Szabó C., Scott G.S., Virág L., Egnaczyk G., Salzman A.L., Shanley T.P., Haskó G. Suppression of macrophage inflammatory protein (MIP)-1α production and collagen-induced arthritis by adenosine receptor agonists. Br. J. Pharmacol. 125:1998;379-387.
268. Taiwo Y.O., Levine J.D. Direct cutaneous hyperalgesia induced by adenosine. Neuroscience. 38:1990;757-762.
269. Thorn J.A., Jarvis S.M. Adenosine transporters. Gen. Pharmacol. 27:1996;613-620.
270. Tjølsen A., Berge O.G., Hunskaar S., Rosland J.H., Hole K. The formalin test: an evaluation of the method. Pain. 51:1992;5-17.
271. Tominga M., Caterina M.J., Malmberg A.B., Rosen T.A., Gilbert H., Skinner K., Raumann B.E., Basbaum A.I., Julius D. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron. 21:1998;1-20.
272. Tsuda M., Ueno S., Inoue K. Evidence for the involvement of spinal endogenous ATP and P2X receptors in nociceptive responses caused by formalin and capsaicin in mice. Br. J. Pharmacol. 128:1999;1497-1504.
273. 2/3 receptor signalling in capsaicin-insensitive primary afferent neurons. J. Neurosci. 20:2000;1-5.
274. 3 mRNA expression by peripheral nerve injury in intact and injured neurons in the rat sensory ganglia. Pain. 91:2001;351-360.
275. 2/3 receptors. Mol. Pharmacol. 53:1998;969-973.
276. Von Lubitz D.K.J.E. Adenosine and cerebral ischemia: therapeutic future or death of a brave concept? Eur. J. Pharmacol. 365:1999;9-25.
277. Watkins L.R., Milligan E.D., Maier S.F. Spinal cord glia: new players in pain. Pain. 93:2001;201-205.
278. + and veratridine-induced release of ATP from synaptosomes prepared from dorsal and ventral spinal cord. Brain Res. 334:1985;372-374.
279. Woolf C.J., Doubell T.P. The pathophysiology of chronic pain - increased sensitivity to low threshold Aβ-fibre inputs. Curr. Opin. Neurobiol. 4:1994;525-534.
280. Woolf C.J., Salter M.W. Neuronal plasticity: increasing the gain in pain. Science. 288:2000;1765-1768.
281. Wu X., Nicol G.D., Meller S.T., Vasko M.R. ATP enhances the evoked release of neuropeptides from rat sensory neurons. Soc. Neurosci. Abstr. 23:1997;1534.
282. 3 receptors. Neuroscience. 114:2002;523-527.
283. Xu G.Y., Huang L.Y.M. Peripheral inflammation sensitizes P2X receptor-mediated responses in rat dorsal root ganglion neurons. J. Neurosci. 22:2002;93-102.
284. Yaksh T.L., Farb D.H., Leeman S.E., Jessell T.M. Intrathecal capsaicin depletes substance P in the rat spinal cord and produces prolonged thermal analgesia. Science. 206:1979;481-483.
285. Yang S.W., Zhang Z.H., Chen J.Y., Xie Y.F., Qiao J.T., Dafny N. Morphine and norepinephrine-induced antinociception at the spinal level is mediated by adenosine. NeuroReport. 5:1994;1441-1444.
286. Yang S.W., Chen J.Y., Zhang Z.H., Xie Y.F., Qiao J.T., Dafny N. Adenosine and opiate-like substances mediates antinociception at the spinal cord. Brain Res. 673:1995;170-174.
287. Yang S.W., Liu R.J., Qiao J.T., Laufman L.E., Dafny N. Adenosine mediates spinal norepinephrine-produced antinociception as revealed by nociceptive discharges in parafascicular neurons in rats. Brain Res. 798:1998;320-324.
288. Yashpal K., Henry J.L. Adenosine receptor link in an adrenal opioid-induced antinociception in the rat tail-flick test. Neurosci. Lett. 138:1992;253-256.
289. Yonehara N., Yoshimura M. Influence of painful chronic neuropathy on neurogenic inflammation. Pain. 92:2001;259-265.
290. Zarate E., Sá Régo M.M., White P.F., Duffy L., Shearer V.E., Griffin J.D., Whitten C.W. Comparison of adenosine and remifentanil infusions as adjuvants to desflurate anaesthesia. Anesthesiology. 90:1999;956-963.
291. 2A receptors. Eur. J. Pharmacol. 313:1996;237-242.
292. Zhou L., Zhang Q., Stein C., Schafer M. Contribution of opioid receptors on primary afferent versus sympathetic neurons to peripheral opioid analgesia. J. Pharmacol. Exp. Ther. 286:1998;1000-1006.
293. Zhou J., Chung K., Chung J.M. Development of purinergic sensitivity in sensory neurons after peripheral nerve injury in the rat. Brain Res. 915:2001;161-169.
294. Zhu C.Z., Mikusa J., Chu K.L., Cowart M., Kowaluk E.A., Jarvis M.F., McGaraughty S. A-134974: a novel adenosine kinase inhibitor, relieves tactile allodynia via spinal sites of action in peripheral nerve injured rats. Brain Res. 905:2001;104-110.
295. Zimmermann H. 5′-Nucleotidase - molecular structure and functional aspects. Biochem. J. 285:1992;345-365.
296. Zimmermann H. Biochemistry, localization and functional roles of ecto-nucleotidases in the nervous system. Prog. Neurobiol. 49:1996;589-618.
297. Zimmermann H. Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch. Pharmacol. 362:2000;299-309.
298. Zimmermann H., Braun N., Kegel B., Heine P. New insights into molecular structure and function of ectonucleotidases in the nervous system. Neurochem. Int. 32:1998;421-425.
299. Zong X., Lux H.D. Augmentation of calcium channel currents in response to G protein activation by GTP gamma S in chick sensory neurons. J. Neurosci. 14:1994;4847-4853.